Radiopharmaceutical Market - Global Industry Analysis

Radiopharmaceutical Market - By Radioisotope Type (Technetium-99, Fluorine-18, Iodine-131, and Leutetium-177), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, and Nephrology), By Source (Cyclotrons and Nuclear Reactors), and By End-User (Hospitals and Diagnostic Labs): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2022 – 2028

Published Date: 08-Apr-2022 Category: Pharmaceutical Report Format : PDF Pages: 190 Report Code: ZMR-86 Status : Published

The global Radiopharmaceutical Market accrued earnings worth approximately 5.8(USD Billion) in 2021 and is predicted to gain revenue of about 11.9(USD Billion) by 2028, is set to record a CAGR of nearly 8.2% over the period from 2022 to 2028.

Description

The global Radiopharmaceutical Market accrued earnings worth approximately 5.8(USD Billion) in 2021 and is predicted to gain revenue of about 11.9(USD Billion) by 2028, is set to record a CAGR of nearly 8.2% over the period from 2022 to 2028. The study provides assessment and analysis of the Radiopharmaceutical Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Radiopharmaceutical Market: Outlook

Radiopharmaceuticals are a class of radioactive substances that can be utilized for therapeutic purpose or diagnostic purpose. Moreover, radiopharmaceuticals find large-scale applications in breast cancer and neuroendocrine tumors. In addition to this, the product also finds myriad utility in nuclear medicine. However, administration of radiopharmaceuticals is systemic and they are projected to be restricted to particular tissues owing to its bio-molecular features. Additionally, radiopharmaceuticals actively emit radiation and this makes their storage difficult in comparison to non-radioactive pharmaceuticals. This has restricted use of radiopharmaceuticals.

Global Radiopharmaceutical Market

Radiopharmaceutical Market: Growth Drivers

Rise in occurrence of ailments such as heart disorders, neurological ailments, and cancer will boost radiopharmaceutical market trends. Prominent surge in use of nuclear medicine in oncology has prompted demand for radiopharmaceuticals in recent years. In addition to this, launching of new technologies in nuclear imaging systems including PET and SPECT will prop up expansion of radiopharmaceutical industry. Nevertheless, huge costs of producing radiopharmaceuticals against ROI and strict laws governing radioactive emissions will put brakes on growth of radiopharmaceutical industry.

Furthermore, surge in research & development activities is projected to steer growth of radiopharmaceutical industry. Moreover, surge in patient awareness, need of precise diagnosis, and rise in use of molecular imaging techniques will embellish growth of radiopharmaceutical market. Use of monoclonal antibodies & radiolabeled peptides for identifying and treating malignant tumors will steer expansion of radiopharmaceuticals industry. Need for treating various kinds of diseases and massive use of targeted treatments such as radiopharmaceutical therapy will proliferate expansion of radiopharmaceutical market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Radiopharmaceutical Market: Regional Landscape

North America To Make Notable Contributions Towards Regional Market Size By 2028

Expansion of radiopharmaceutical market in North America over forecasting years can be attributed to rise in occurrence of chronic disorders such as heart ailments and cancer in countries such as the U.S. In addition to this, surging aging populace and changing lifestyles    has resulted in obesity leading to huge sale of nuclear drugs. This has driven growth of regional market. Acceptance of new technologies for radioisotope production for treating chronic ailments will result in expansion of radiopharmaceuticals market in countries such as the U.S.

Breakthroughs in Radiopharmaceutical Market

  • In March 2022, GE Healthcare declared first patient dosed in its phase III clinical experiments for PET radiopharmaceutical imaging agents. It is likely to carry out clinical trial for SPECT radiopharmaceutical imaging agent in next phase. The strategic move is aimed at diagnosing adult population for Parkinson syndrome along with enhancing patient care services. Reportedly, GE Healthcare is planning to augment its radiopharmaceutical portfolio through these two pipeline radiopharmaceuticals, one for PET and another for SPECT.  
  • In March 2022, Novartis AG won approval of U.S. Food and Drug Administration for selling radiopharmaceutical for treating advanced stage of prostate cancer.
  • In April 2022, Iran has unleashed new generation of radiopharmaceutical referred as LU-177. It is developed by Iranian scientists and is used for diagnosing as well as curing various kinds of cancerous tissues. Moreover, LU-177 has ability to kill cancer tumor tissues by linking to tumor receptors. The mechanism of LU-177 is expected to prevent metastatis through disruption of circulating blood near tumors.

Radiopharmaceutical Market: Competitive Insights

Some of the major players have lucratively impacted growth of radiopharmaceutical industry and are predicted to do so even in near future. They are Jubilant Pharmova, Lantheus Holdings Inc., Mallinckrodt Pharmaceuticals, Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications, The Bracco Group, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Bayer AG, IBA Molecular Imaging Private Limited, and Siemens Healthineers AG.

The global Radiopharmaceutical Market is segmented as follows:

By Radioisotope Type

  • Technetium-99
  • Fluorine-18
  • Iodine-131
  • Leutetium-177

By Application

  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinology
  • Neurology
  •  Nephrology

By Source

  • Cyclotrons
  • Nuclear Reactors

By End-User

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Radiopharmaceutical Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Radiopharmaceutical Market : snapshot
  • Chapter 3. Global Radiopharmaceutical Market - Industry Analysis
    • 3.1 Radiopharmaceutical Market: Market Dynamics
    • 3.2 Market Drivers
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By By Radioisotope Type
      • 3.7.2 Market attractiveness analysis By By Application
      • 3.7.3 Market attractiveness analysis By By Source
      • 3.7.4 Market attractiveness analysis By By End-User
  • Chapter 4. Global Radiopharmaceutical Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Radiopharmaceutical Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Radiopharmaceutical Market - By Radioisotope Type Analysis
    • 5.1 Global Radiopharmaceutical Market overview: By By Radioisotope Type
      • 5.1.1 Global Radiopharmaceutical Market share, By By Radioisotope Type, 2021 and 2028
    • 5.2 Technetium-99
      • 5.2.1 Global Radiopharmaceutical Market by Technetium-99, 2022 - 2028 (USD Billion)
    • 5.3 Fluorine-18
      • 5.3.1 Global Radiopharmaceutical Market by Fluorine-18, 2022 - 2028 (USD Billion)
    • 5.4 Iodine-131
      • 5.4.1 Global Radiopharmaceutical Market by Iodine-131, 2022 - 2028 (USD Billion)
    • 5.5 Leutetium-177
      • 5.5.1 Global Radiopharmaceutical Market by Leutetium-177, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Radiopharmaceutical Market - By Application Analysis
    • 6.1 Global Radiopharmaceutical Market overview: By By Application
      • 6.1.1 Global Radiopharmaceutical Market share, By By Application, 2021 and 2028
    • 6.2 Oncology
      • 6.2.1 Global Radiopharmaceutical Market by Oncology, 2022 - 2028 (USD Billion)
    • 6.3 Cardiology
      • 6.3.1 Global Radiopharmaceutical Market by Cardiology, 2022 - 2028 (USD Billion)
    • 6.4 Gastroenterology
      • 6.4.1 Global Radiopharmaceutical Market by Gastroenterology, 2022 - 2028 (USD Billion)
    • 6.5 Neuroendocrinology
      • 6.5.1 Global Radiopharmaceutical Market by Neuroendocrinology, 2022 - 2028 (USD Billion)
    • 6.6 Neurology
      • 6.6.1 Global Radiopharmaceutical Market by Neurology, 2022 - 2028 (USD Billion)
    • 6.7  Nephrology
      • 6.7.1 Global Radiopharmaceutical Market by  Nephrology, 2022 - 2028 (USD Billion)
  • Chapter 7. Global Radiopharmaceutical Market - By Source Analysis
    • 7.1 Global Radiopharmaceutical Market overview: By By Source
      • 7.1.1 Global Radiopharmaceutical Market share, By By Source, 2021 and 2028
    • 7.2 Cyclotrons
      • 7.2.1 Global Radiopharmaceutical Market by Cyclotrons, 2022 - 2028 (USD Billion)
    • 7.3 Nuclear Reactors
      • 7.3.1 Global Radiopharmaceutical Market by Nuclear Reactors, 2022 - 2028 (USD Billion)
  • Chapter 8. Global Radiopharmaceutical Market - By End-User Analysis
    • 8.1 Global Radiopharmaceutical Market overview: By By End-User
      • 8.1.1 Global Radiopharmaceutical Market share, By By End-User, 2021 and 2028
    • 8.2 Hospitals
      • 8.2.1 Global Radiopharmaceutical Market by Hospitals, 2022 - 2028 (USD Billion)
    • 8.3 Diagnostic Labs
      • 8.3.1 Global Radiopharmaceutical Market by Diagnostic Labs, 2022 - 2028 (USD Billion)
  • Chapter 9. Radiopharmaceutical Market - Regional Analysis
    • 9.1 Global Radiopharmaceutical Market Regional Overview
    • 9.2 Global Radiopharmaceutical Market Share, by Region, 2021 & 2028 (USD Billion)
    • 9.3. North America
      • 9.3.1 North America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
        • 9.3.1.1 North America Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 North America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
      • 9.4.1 North America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
    • 9.5 North America Radiopharmaceutical Market, by By Application, 2022 - 2028
      • 9.5.1 North America Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
    • 9.6 North America Radiopharmaceutical Market, by By Source, 2022 - 2028
      • 9.6.1 North America Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
    • 9.7 North America Radiopharmaceutical Market, by By End-User, 2022 - 2028
      • 9.7.1 North America Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
    • 9.4. Europe
      • 9.4.2 Europe Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
        • 9.4.2.1 Europe Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 Europe Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
      • 9.4.1 Europe Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
    • 9.5 Europe Radiopharmaceutical Market, by By Application, 2022 - 2028
      • 9.5.1 Europe Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
    • 9.6 Europe Radiopharmaceutical Market, by By Source, 2022 - 2028
      • 9.6.1 Europe Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
    • 9.7 Europe Radiopharmaceutical Market, by By End-User, 2022 - 2028
      • 9.7.1 Europe Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
        • 9.5.3.1 Asia Pacific Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 Asia Pacific Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
      • 9.4.1 Asia Pacific Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
    • 9.5 Asia Pacific Radiopharmaceutical Market, by By Application, 2022 - 2028
      • 9.5.1 Asia Pacific Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
    • 9.6 Asia Pacific Radiopharmaceutical Market, by By Source, 2022 - 2028
      • 9.6.1 Asia Pacific Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
    • 9.7 Asia Pacific Radiopharmaceutical Market, by By End-User, 2022 - 2028
      • 9.7.1 Asia Pacific Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
    • 9.6. Latin America
      • 9.6.4 Latin America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
        • 9.6.4.1 Latin America Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 Latin America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
      • 9.4.1 Latin America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
    • 9.5 Latin America Radiopharmaceutical Market, by By Application, 2022 - 2028
      • 9.5.1 Latin America Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
    • 9.6 Latin America Radiopharmaceutical Market, by By Source, 2022 - 2028
      • 9.6.1 Latin America Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
    • 9.7 Latin America Radiopharmaceutical Market, by By End-User, 2022 - 2028
      • 9.7.1 Latin America Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
        • 9.7.5.1 The Middle-East and Africa Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
    • 9.4 The Middle-East and Africa Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
      • 9.4.1 The Middle-East and Africa Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
    • 9.5 The Middle-East and Africa Radiopharmaceutical Market, by By Application, 2022 - 2028
      • 9.5.1 The Middle-East and Africa Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
    • 9.6 The Middle-East and Africa Radiopharmaceutical Market, by By Source, 2022 - 2028
      • 9.6.1 The Middle-East and Africa Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
    • 9.7 The Middle-East and Africa Radiopharmaceutical Market, by By End-User, 2022 - 2028
      • 9.7.1 The Middle-East and Africa Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1 Jubilant Pharmova
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Lantheus Holdings Inc.
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Mallinckrodt Pharmaceuticals
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Cardinal Health Inc.
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 GE Healthcare
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Advanced Accelerator Applications
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 The Bracco Group
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Eczacibasi-Monrol Nuclear Products
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Nordion Inc.
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Bayer AG
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 IBA Molecular Imaging Private Limited
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 Siemens Healthineers AG.
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Radiopharmaceutical Market attractiveness, By By Radioisotope Type
  • 6. Global Radiopharmaceutical Market attractiveness, By By Application
  • 7. Global Radiopharmaceutical Market attractiveness, By By Source
  • 8. Global Radiopharmaceutical Market attractiveness, By By End-User
  • 9. Global Radiopharmaceutical Market share by By Radioisotope Type, 2022 and 2028 (USD Billion)
  • 10. Global Radiopharmaceutical Market by Technetium-99, 2022 - 2028 (USD Billion)
  • 11. Global Radiopharmaceutical Market by Fluorine-18, 2022 - 2028 (USD Billion)
  • 12. Global Radiopharmaceutical Market by Iodine-131, 2022 - 2028 (USD Billion)
  • 13. Global Radiopharmaceutical Market by Leutetium-177, 2022 - 2028 (USD Billion)
  • 14. Global Radiopharmaceutical Market share by By Application, 2022 and 2028 (USD Billion)
  • 15. Global Radiopharmaceutical Market by Oncology, 2022 - 2028 (USD Billion)
  • 16. Global Radiopharmaceutical Market by Cardiology, 2022 - 2028 (USD Billion)
  • 17. Global Radiopharmaceutical Market by Gastroenterology, 2022 - 2028 (USD Billion)
  • 18. Global Radiopharmaceutical Market by Neuroendocrinology, 2022 - 2028 (USD Billion)
  • 19. Global Radiopharmaceutical Market by Neurology, 2022 - 2028 (USD Billion)
  • 20. Global Radiopharmaceutical Market by  Nephrology, 2022 - 2028 (USD Billion)
  • 21. Global Radiopharmaceutical Market share by By Source, 2022 and 2028 (USD Billion)
  • 22. Global Radiopharmaceutical Market by Cyclotrons, 2022 - 2028 (USD Billion)
  • 23. Global Radiopharmaceutical Market by Nuclear Reactors, 2022 - 2028 (USD Billion)
  • 24. Global Radiopharmaceutical Market share by By End-User, 2022 and 2028 (USD Billion)
  • 25. Global Radiopharmaceutical Market by Hospitals, 2022 - 2028 (USD Billion)
  • 26. Global Radiopharmaceutical Market by Diagnostic Labs, 2022 - 2028 (USD Billion)
  • 27. Global Radiopharmaceutical Market share, by Region, 2022 and 2028
  • 28. North America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
  • 29. Europe Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
  • 30. Asia Pacific Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
  • 31. Latin America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
  • 32. The Middle-East and Africa Radiopharmaceutical Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Radiopharmaceutical Market: Snapshot
  • 2. Drivers of the Radiopharmaceutical Market: impact analysis
  • 3. North America Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 4. North America Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 5. North America Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 6. North America Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 7. U.S. Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 8. U.S. Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 9. U.S. Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 10. U.S. Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 11. Canada Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 12. Canada Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 13. Canada Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 14. Canada Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 15. Europe Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 16. Europe Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 17. Europe Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 18. Europe Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 19. Germany Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 20. Germany Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 21. Germany Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 22. Germany Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 23. France Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 24. France Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 25. France Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 26. France Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 27. U.K. Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 28. U.K. Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 29. U.K. Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 30. U.K. Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 31. Italy Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 32. Italy Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 33. Italy Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 34. Italy Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 35. Spain Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 36. Spain Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 37. Spain Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 38. Spain Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 39. Rest of Europe Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 40. Rest of Europe Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 41. Rest of Europe Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 42. Rest of Europe Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 43. Asia Pacific Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 44. Asia Pacific Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 45. Asia Pacific Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 46. Asia Pacific Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 47. China Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 48. China Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 49. China Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 50. China Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 51. Japan Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 52. Japan Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 53. Japan Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 54. Japan Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 55. India Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 56. India Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 57. India Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 58. India Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 59. South Korea Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 60. South Korea Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 61. South Korea Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 62. South Korea Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 63. South-East Asia Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 64. South-East Asia Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 65. South-East Asia Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 66. South-East Asia Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 67. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 68. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 69. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 70. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 71. Latin America Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 72. Latin America Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 73. Latin America Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 74. Latin America Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 75. Brazil Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 76. Brazil Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 77. Brazil Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 78. Brazil Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 79. Mexico Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 80. Mexico Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 81. Mexico Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 82. Mexico Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 83. Rest of Latin America Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 84. Rest of Latin America Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 85. Rest of Latin America Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 86. Rest of Latin America Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 87. The Middle-East and Africa Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 88. The Middle-East and Africa Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 89. The Middle-East and Africa Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 90. The Middle-East and Africa Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 91. GCC Countries Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 92. GCC Countries Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 93. GCC Countries Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 94. GCC Countries Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 95. South Africa Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 96. South Africa Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 97. South Africa Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 98. South Africa Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
  • 99. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
  • 100. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
  • 101. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
  • 102. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Radiopharmaceutical market. Zion Research has collected and analyzed key data belong to the global Radiopharmaceutical market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Radiopharmaceutical across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Radiopharmaceutical industry. Primary research makes up a major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Radiopharmaceutical market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Radiopharmaceuticals are therapeutic agents used to diagnose certain medical condition or treat certain diseases. Unlike other imaging techniques such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound (US), nuclear medicine processes are capable of mapping metabolic activity and physiological function. Radiopharmaceutical procedure provides more precise information about the organ function or dysfunction. Nuclear medicine may be given to the patient in various different ways. They may be given by injection, given orally, or placed into the bladder.

 Radiopharmaceuticals are to be given only under the direct supervision of a doctor with specialized training in nuclear medicine. Radiopharmaceutical process is rigorously regulated by the European Medicines Agency (EMA) in Europe and Food and Drug Administration (FDA) in the U.S. General interval for approval of process is typically five to eight years, from the early discovery to the availability for the physicians.

Radiopharmaceutical market growth is triggered by growing demand for PET and SPECT radioisotopes. Single-photon emission computed tomography (SPECT) and Positron emission tomography (PET) are the nuclear medicine imaging techniques.  Other factors contributing to this growth include increasing incidences of cancer and heart diseases.. However, factors such as stringent regulatory guidelines, shorter half-life of nuclear medicine and competition from conventional diagnostic procedures can affect the growth of this market.

Radiopharmaceutical market is segmented on the basis of type, application and region. On the basis of type radiopharmaceutical market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals.  The diagnostics segment is classified into SPECT and PET. Diagnostic radiopharmaceuticals segment acquired largest market in 2015 owing to well established use of radio isotopes in diagnostic imaging. Cardiology and oncology are the core application areas of for diagnostic radiopharmaceutical.  The therapeutic radiopharmaceuticals segment is expected to show fastest growth in forecast period due to its advantages over traditional therapies and drugs. The therapeutics segment is further divided into beta emitters, alpha emitters, and brachytherapy isotopes.

Radiopharmaceutical application segment includes cardiology, neurology, oncology, and other. Cardiology application segment accounted for significant share of radiopharmaceutical market in 2015. Cancer is, therefore, emerging as a lucrative application area for radiopharmaceuticals industry.

Geographically, the global radiopharmaceutical market is segmented into North America, Europe, Latin America, Asia-Pacific, and Middle East and Africa. The radiopharmaceutical market was dominated by North America accounting for the largest share of the total market in 2015. In 2015, U.S. accounted for the major share of the North American radiopharmaceuticals market, followed by Canada. The key factors driving market growth in the U.S. include approval for new nuclear medicine by the FDA in this region. An alternative treatment for cancer and growing prevalence of thyroid cancer also boosts the global radiopharmaceutical market growth.

The Asia-Pacific radiopharmaceuticals market is expected to grow at the fastest rate during the forecast period owing to a rise in the demand for PET and SPECT devices coupled with rising patient awareness for cardiovascular diseases and oncology.

Some of the major players in the radiopharmaceuticals market include Cardinal Health, Inc., GE Healthcare, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A., Bayer Healthcare, Lantheus Medical Imaging, Inc., IBA Molecular Imaging, Mallinckrodt plc, Jubilant Pharma, and Siemens Healthcare.

Choose License Type

FrequentlyAsked Questions

Rise in occurrence of ailments such as heart disorders, neurological ailments, and cancer will boost radiopharmaceutical market trends.

According to Zion market research report, the global Radiopharmaceutical Market accrued earnings worth approximately 5.8(USD Billion) in 2021 and is predicted to gain revenue of about 11.9(USD Billion) by 2028, is set to record a CAGR of nearly 8.2% over the period from 2022 to 2028.

North America will contribute sizably towards the global market revenue over the projected timeline. A massive increase in Radiopharmaceutical Market size in sub-continent over 2022-2028 can be due to rise in occurrence of chronic disorders such as heart ailments and cancer in countries such as the U.S.

The key industry participants leveraging business space include Jubilant Pharmova, Lantheus Holdings Inc., Mallinckrodt Pharmaceuticals, Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications, The Bracco Group, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Bayer AG, IBA Molecular Imaging Private Limited, and Siemens Healthineers AG.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed